The Sacklers’ settlement includes a release that can shield them and others like them from legal consequences. The ramifications are huge.

GOP leaders brazenly skirted a state Supreme Court ruling with a law shielding the money from public scrutiny. Many other states are doing likewise. Are we repeating the tobacco settlement debacle?

“All The Beauty And The Bloodshed,” Laura Poitras’s documentary about Nan Goldin, is part portrait of the artist, part exposé.

Urban legends about poisoned candy have changed to match the times.

Politicians and lawmakers are equating large-scale fentanyl seizures with progress in combating the drug’s epidemic, forgetting the lessons from the age of crack.

The California governor’s shock veto of a bill that would have created safe injection sites is a shameful play for major donors who would fuel a future presidential run, at the expense of his most vulnerable constituents.

The U.S. has treatments to help people dealing with opioid addictions but throws up hurdles to access.

A $26 billion deal is now in local governments’ hands. It could go to harm reduction or toward police and politicians’ pet concerns.

In the shadow of the Covid-19 pandemic, the number of overdose deaths surged past 100,000 for the first time in 2021.

In the face of unprecedented opioid overdose deaths, the people most at risk can’t reliably access care—including life-saving treatments like methadone and buprenorphine.

Federal drug policy needs a major overhaul, but Rahul Gupta has a record of making harmful compromises.

Thanks to one judge, members of the family that made billions from OxyContin could escape justice for their role in the opioid epidemic. Mike Quinn may be the best hope of holding them to account.

Patrick Radden Keefe’s new book provides the fullest accounting so far of Purdue Pharma’s role in the opioid crisis.

The line between legal pharmaceuticals and illegal drugs has less to do with science than with race, class, and gender.

Rock Springs, Wyoming, sits on vast underground stores of natural gas and shale oil. But what was meant to be a blessing turned into a curse.

From Purdue to Google, what explains the Trump administration’s recent surge in white-collar cases?

America is putting an awful lot of trust in a pharmaceutical industry that hasn’t earned it.

The George Floyd protests have spread to the heavily white areas of rural Ohio. Only time will tell whether the alliance will last.

Sanders's New Hampshire operation is a model for fusing movement politics with a presidential campaign. Can he replicate that model across the country?

BioCorRx facilitated an anti-opioid implantation in an incarcerated person earlier this year. But the procedure hadn’t been approved by the FDA.